Product Approval Information - Licensing Action
Proper name: BCG, Live
Tradename: PACIS
Manufacturer: BioChem Pharma Inc, Sainte-Foy, Quebec, Canada, License #1283
Indication for Use: Treatment of carcinoma-in-situ (CIS) in the absence of associated invasive cancer of the bladder
Approval Date: 3/9/2000
Type of submission: Biologics license application
Approval Letter -
(PDF),
(Text)
Label - (PDF)
|